MiMedx’s leadership begins to unravel following internal and external investigations

MiMedx’s board of directors has decided to replace its president and its CEO as a result of an ongoing internal investigation and federal probes into its accounting and sales compliance practices, less than a month after the company said it would need to restate five years’ worth of financial disclosures.